A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Susan Rheingold, MD
Children's Hospital of Philadelphia
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Royal Children'S Hospital
Brisbane, Queensland, Australia
- Royal Children'S Hospital, Melbourne
Melbourne, Victoria, Australia
- Sydney Children'S Hospital
Sydney, Australia
- Hospital for Sick Kids
Toronto, Ontario, Canada
- Sainte Justine University Hospital
Montreal, Quebec, Canada
- British Columbia Children'S Hospital
Vancouver, Canada
- Childrens Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Orange County
Orange, California, United States
- Ucsf School of Medicine
San Francisco, California, United States
- the Children'S Hospital, University of Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Miami Cancer Center
Miami, Florida, United States
- Children'S Healthcare of Atlanta, Emory University
Atlanta, Georgia, United States
- Lurie Children'S Hospital
Chicago, Illinois, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Dana Farber
Boston, Massachusetts, United States
- C.S. Mott Children'S Hospital
Ann Arbor, Michigan, United States
- Childrens Hospital & Clinics of Minnesota
Minneapolis, Minnesota, United States
- Children'S Hospital New York-Presbyterian
New York, New York, United States
- Levine Children'S Hospital at Carolinas Medical Center
Charlotte, North Carolina, United States
- Rainbow Babies
Cleveland, Ohio, United States
- Nationwide Childrens Hospital
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- St. Jude
Memphis, Tennessee, United States
- University of Texas at Southwestern
Dallas, Texas, United States
- Cook Children'S Medical Center
Fort Worth, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Primary Children'S
Salt Lake City, Utah, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jul 2015
- Primary completion
- 15 Dec 2019
- Completion
- 4 Sept 2020
- Last update posted
- 27 Jul 2023
- Registered enrollment
- 16
- Registry id
- NCT01614197
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.